{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-001421","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2026-08-27T12:30:31+00:00","discovered_at":"2026-08-27T12:35:00.391344+00:00","generated_at":"2026-08-27T12:35:10.495107+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Artelo Biosciences announces 1-for-9 reverse stock split effective Aug 28, 2026","bullets":["Reverse split ratio 1-for-9, effective 5:00 p.m. ET Aug 28, 2026; split-adjusted trading begins Aug 31, 2026.","Outstanding shares reduced from 4,929,966 to ~547,774; authorized shares cut from 500M to 55,555,556.","New CUSIP 04301G805; no fractional shares, each fractional share rounds up to one whole share.","Warrants and derivatives adjust per terms; shareholder pro-rata ownership unchanged.","Purpose: improve marketability and liquidity of common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-001421","json":"https://secwatch.observer/filing/0001640334-26-001421.json","markdown":"https://secwatch.observer/filing/0001640334-26-001421.md","text":"https://secwatch.observer/filing/0001640334-26-001421.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/0001640334-26-001421-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426001421/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-27T12:35:10.495107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}